LEADER 02282nam  22005534a 450 
001 9910778746103321
005 20230422031329.0
010   $a0-309-17280-2
010   $a0-309-52024-X
010   $a0-585-14261-0
035   $a(CKB)110986584752810
035   $a(EBL)3375557
035   $a(SSID)ssj0000106903
035   $a(PQKBManifestationID)11131790
035   $a(PQKBTitleCode)TC0000106903
035   $a(PQKBWorkID)10012316
035   $a(PQKB)10106091
035   $a(MiAaPQ)EBC3375557
035   $a(Au-PeEL)EBL3375557
035   $a(CaPaEBR)ebr10040974
035   $a(OCoLC)830028287
035   $a(EXLCZ)99110986584752810
100   $a20000303d1999      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aAssuring data quality and validity in clinical trials for regulatory decision making$b[electronic resource] $eworkshop report : Roundtable on Research and Development of Drugs, Biologics, and Medical Devices /$fJonathan R. Davis ... [et al.] editors
210   $aWashington, DC $cNational Academy Press$dc1999
215   $a1 online resource (88 p.)
225 1 $aThe compass series
300   $aDescription based upon print version of record.
311   $a0-309-06594-1 
320   $aIncludes bibliographical references (p. 75-76).
327   $aFront Matter; Preface; Acknowledgments; Contents; Executive Summary; Introduction; Presubmission and Submission; FDA Regulatory Review; Summary of Issues; Directions for the Future; Final Comments; APPENDIX A Workshop Agenda; APPENDIX B Speakers and Panelists; APPENDIX C Workshop Registrants; APPENDIX D Glossary and Acronyms
410  0$aCompass series (Washington, D.C.)
606   $aClinical trials$xQuality control
615  0$aClinical trials$xQuality control.
676   $a615/.1
701   $aDavis$b Jonathan R$01474203
712 02$aInstitute of Medicine (U.S.).$bRoundtable on Research and Development of Drugs, Biologics, and Medical Devices.
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910778746103321
996   $aAssuring data quality and validity in clinical trials for regulatory decision making$93687739
997   $aUNINA